Gabriella Camboni

984 total citations
26 papers, 821 citations indexed

About

Gabriella Camboni is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Gabriella Camboni has authored 26 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Gabriella Camboni's work include Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Gastroesophageal reflux and treatments (3 papers). Gabriella Camboni is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Gastroesophageal reflux and treatments (3 papers). Gabriella Camboni collaborates with scholars based in Italy, United Kingdom and Germany. Gabriella Camboni's co-authors include Giovanna Damia, P.A. Bianchi, Guido Basilisco, Silvia Marsoni, A. Bernareggi, Duncan I. Jodrell, Gennaro Colella, Raffaella Giavazzi, Alexander Berndt and Ezia Bello and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gut.

In The Last Decade

Gabriella Camboni

25 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriella Camboni Italy	17	349	341	159	139	108	26	821
Marek Majewski Poland	15	215 0.6×	197 0.6×	142 0.9×	37 0.3×	93 0.9×	57	1.1k
Mario Turriziani Italy	20	454 1.3×	332 1.0×	89 0.6×	58 0.4×	9 0.1×	39	1.2k
William Q. Sargent United States	7	311 0.9×	206 0.6×	55 0.3×	87 0.6×	23 0.2×	14	698
Ajay Bhargava United States	19	516 1.5×	247 0.7×	217 1.4×	46 0.3×	12 0.1×	47	1.1k
Emanuela Marchesi Italy	19	271 0.8×	297 0.9×	102 0.6×	102 0.7×	13 0.1×	44	1.2k
Yiping Zhu China	14	280 0.8×	354 1.0×	205 1.3×	20 0.1×	38 0.4×	47	773
Olga P. Bondar United States	12	300 0.9×	63 0.2×	77 0.5×	25 0.2×	140 1.3×	18	702
Paul E. Finke United States	23	559 1.6×	378 1.1×	461 2.9×	39 0.3×	13 0.1×	45	1.6k
Weiliang Ding China	17	257 0.7×	187 0.5×	71 0.4×	62 0.4×	7 0.1×	37	755
Jochen Zisowsky Switzerland	9	286 0.8×	341 1.0×	49 0.3×	219 1.6×	8 0.1×	17	789

Countries citing papers authored by Gabriella Camboni

Since Specialization

Citations

This map shows the geographic impact of Gabriella Camboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Camboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Camboni more than expected).

Fields of papers citing papers by Gabriella Camboni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Camboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Camboni. The network helps show where Gabriella Camboni may publish in the future.

Co-authorship network of co-authors of Gabriella Camboni

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Camboni. A scholar is included among the top collaborators of Gabriella Camboni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Camboni. Gabriella Camboni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camboni, Gabriella, Jared Cartwright, & Gideon Grogan. (2025). Identification of improved signal peptides for heterologous expression in Saccharomyces using a screen that exploits Gaussia luciferase. Scientific Reports. 15(1). 23962–23962. 2 indexed citations

Bello, Ezia, Giulia Taraboletti, Gennaro Colella, et al.. (2012). The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts. Molecular Cancer Therapeutics. 12(2). 131–140. 39 indexed citations

Bello, Ezia, Gennaro Colella, Paolo Oliva, et al.. (2011). E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models. Cancer Research. 71(4). 1396–1405. 117 indexed citations

Colella, Gennaro, Giovanna Damia, Maurizio D’Incalci, et al.. (2011). Abstract 595: E-3810 antitumor activity in human xenografts expressing different levels of FGF receptor 1. Cancer Research. 71(8_Supplement). 595–595. 2 indexed citations

Bichat, Francis, et al.. (2010). Abstract 1367: The dual selective VEGFR-FGFR kinases inhibitor E-3810 decreases tumor perfusion and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging. Cancer Research. 70(8_Supplement). 1367–1367. 2 indexed citations

Marsoni, Silvia, Giovanna Damia, & Gabriella Camboni. (2008). A work in progress: The clinical development of histone deacetylase inhibitor. Epigenetics. 3(3). 164–171. 68 indexed citations

Jodrell, Duncan I., T.R. Jeffry Evans, William P. Steward, et al.. (2004). Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma. European Journal of Cancer. 40(12). 1872–1877. 104 indexed citations

Gourley, Charlie, James T. Cassidy, Leslie Samuel, et al.. (2004). A phase I study of the trinuclear platinum compound, BBR�3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 53(2). 95–101. 19 indexed citations

Scagliotti, Giorgio V., Silvia Novello, Lucio Crinò, et al.. (2003). P-523 Phase II trial of BBR3464, a novel, bifunctional platinum analog, as second line treatment of non-small cell lung cancer patients. Lung Cancer. 41. S223–S223. 11 indexed citations

10.

Scagliotti, Giorgio V., Filippo de Marinis, Maurizio Tonato, et al.. (2001). Phase II trial of BBR3464, a novel, bifunctional platinum analog, in advanced but favorable out-come, Non Small Cell Lung Cancer patients. European Journal of Cancer. 37. S52–S52. 3 indexed citations

11.

Borchmann, Peter, R. Schnell, Jan Oliver Staak, et al.. (2001). Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin’s lymphoma. Annals of Oncology. 12(5). 661–667. 44 indexed citations

12.

Dawson, L., Duncan I. Jodrell, A. Bowman, et al.. (2000). A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly. European Journal of Cancer. 36(18). 2353–2359. 33 indexed citations

13.

Sessa, Cristiana, Giuseppe Capri, Luca Gianni, et al.. (2000). Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex. Annals of Oncology. 11(8). 977–984. 59 indexed citations

14.

Annibale, Bruno, G. Delle Fave, Cinzia Azzoni, et al.. (1994). Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger‐Ellison syndrome and antral G‐cell hyperfunction. Alimentary Pharmacology & Therapeutics. 8(1). 95–104. 16 indexed citations

15.

Basilisco, Guido, et al.. (1989). Orocecal transit delay in obese patients. Digestive Diseases and Sciences. 34(4). 509–512. 39 indexed citations

16.

Basilisco, Guido, et al.. (1989). Intragastric and intraoesophagel pH monitoring in duodenal ulcer patients: effect of the new histamine H2-receptor antagonist ramixotidine. European Journal of Clinical Pharmacology. 37(4). 405–407. 1 indexed citations

17.

Camboni, Gabriella, et al.. (1988). Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit. Digestive Diseases and Sciences. 33(12). 1525–1527. 21 indexed citations

18.

Penagini, Roberto, P. Velio, Gabriella Camboni, et al.. (1986). Lactose malabsorption and intolerance in Italians. Digestive Diseases and Sciences. 31(12). 1313–1316. 34 indexed citations

19.

Basilisco, Guido, Gabriella Camboni, M. Recchia, et al.. (1985). Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.. Gut. 26(7). 700–703. 50 indexed citations

20.

Basilisco, Guido, Gabriella Camboni, M. Recchia, et al.. (1985). Effect ofloperamide andnaloxone onmouth-to-caecum transit timeevaluated bylactulose hydrogen breath test.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact